Preoperative Immuno-Nutrition and Complications After Colorectal Surgery: Results of a 2-Year Prospective Study

• Published in: The Journal of surgical research 2023-09, Vol.289, p.182-189
• Main Authors: Ogilvie, James, Mittal, Rohin, Sangster, William, Parker, Jessica, Lim, Kelvin, Kyriakakis, Roxanne, Luchtefeld, Martin
• Format: Article
• Language: English
• Subjects: Colorectal surgery; Colorectal Surgery - adverse effects; Dietary supplements; Digestive System Surgical Procedures; Enhanced recovery after surgery; Humans; Immunonutrition Diet; Prospective Studies; Surgical Wound Infection - epidemiology; Surgical Wound Infection - etiology; Surgical Wound Infection - prevention & control
• ISSN: 0022-4804; 1095-8673
• DOI: 10.1016/j.jss.2023.03.040

Preoperative immuno-nutrition has been associated with reductions in infectious complications and length of stay, but remains unstudied in the setting of an enhanced recovery protocol. The objective was to evaluate outcomes after elective colorectal surgery with the addition of a preoperative immuno-nutrition supplement. In October 2017, all major colorectal surgeries were given an arginine-based supplement prior to surgery. The control group consisted of cases within the same enhanced recovery protocol from three years prior. The primary outcome was a composite of overall morbidity. Secondary outcomes were infectious complications and length of stay with subgroup analysis based on degrees of malnutrition. Of 826 patients, 514 were given immuno-nutrition prospectively and no differences in complication rates (21.5% versus 23.9%, P = 0.416) or surgical site infections (SSIs) (6.4% versus 6.9%, P = 0.801) were observed. Hospitalization was slightly shorter in the immuno-nutrition cohort (5.0 [3.0, 7.0], versus 5.5 days [3.6, 7.9], P = 0.002). There was a clinically insignificant difference in prognostic nutrition index scores between cohorts (35.2 ± 5.6 versus 36.1 ± 5.0, P = 0.021); however, subgroup analysis (< 33, 34-38 and > 38) failed to demonstrate an association with complications (P = 0.275) or SSIs (P = 0.640) and immuno-nutrition use. Complication rates and SSIs were unchanged with the addition of immuno-nutrition before elective colorectal surgery. The association with length of stay is small and without clinical significance; therefore, the routine use of immuno-nutrition in this setting is of questionable benefit. •Addition of immuno-nutrition to an ERAS pathway did not impact complications rates.•Use of immuno-nutrition did not decrease surgical site infections.•Low Prognostic Nutrition Index scores did not predict benefit from immuno-nutrition.